Brand-name medications are not foregrounded, and no guarantees are made about which options may be available
Angele-Martinez et al., 2017)
TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Fri 24 Jul 2026 at 11:13am In short: The Therapeutic Goods Administration is warning of a rare but serious eye disorder that could be caused by GLP-1-based drugs
Once a pen has been opened or the tamper seal broken, it cannot be returned, standard practice for sterile research consumables
Just last year, the FDA issued a recall of 27 over-the-counter eye drop products due to the risk of infections that could cause partial vision loss and even blindness
In Madagascar, a combination of a cream containing clobetasol propionate 0.05%, oral vitamins C and B 12 and microtrauma suppression proved to be an effective therapy